Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics-Reference-Cited by-同舟云学术

Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics

Published:2016-07-28 Issue:5 Volume:69 Page:727-738
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Clarke Blaise A¹²,Witkowski Leora³⁴,Ton Nu Tuyet N⁵,Shaw Patricia A¹²,Gilks C Blake⁶⁷⁸,Huntsman David⁶⁷⁸,Karnezis Anthony N⁶⁷⁸,Sebire Neil⁹¹⁰,Lamovec Janez¹¹,Roth Lawrence M¹²,Stewart Colin J R¹³¹⁴,Hasselblatt Martin¹⁵,Foulkes William D³⁴¹⁶,McCluggage W Glenn¹⁷

Affiliation:

1. Department of Laboratory Medicine and Pathobiology; University of Toronto; University Health Network; Toronto ON Canada

2. Toronto General Hospital; Toronto ON Canada

3. Department of Human Genetics; McGill University; Montreal QC Canada

4. Lady Davis Institute and Segal Cancer Centre; Jewish General Hospital; Montreal QC Canada

5. Department of Pathology; McGill University Health Centre; Montreal QC Canada

6. Department of Pathology and Laboratory Medicine; The University of British Columbia; Vancouver BC Canada

7. Centre for Translational and Applied Genomics; British Columbia Cancer Agency; Vancouver BC Canada

8. Department of Pathology and Laboratory Medicine; Vancouver General Hospital; Vancouver BC Canada

9. Department of Histopathology; Great Ormond Street Hospital; London UK

10. Institute of Child Health; University College London; London UK

11. Department of Pathology; Institute of Oncology; Ljubljana Slovenia

12. Department of Pathology; Indiana University School of Medicine; Indianapolis IN USA

13. School for Women's and Infants' Health; University of Western Australia; Perth WA Australia

14. KEMH; Perth WA Australia

15. Institute of Neuropathology; University Hospital Münster; Münster Germany

16. Department of Medical Genetics; Research Institute; McGill University Health Centre; Montreal QC Canada

17. Department of Pathology; Belfast Health and Social Care Trust; Royal Group of Hospitals Trust; Royal Group of Hospitals; Belfast UK

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12988/fullpdf

Reference24 articles.

1. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases;Young;Am. J. Surg. Pathol.,1994

2. Ovarian neoplasms composed of small round cells: a review;McCluggage;Adv. Anat. Pathol.,2004

3. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type;McCluggage;Int. J. Gynecol. Pathol.,2004

4. Neuroendocrine tumors of the gynecologic tract: select topics;Rouzbahman;Semin. Diagn. Pathol.,2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes;Cancers;2024-09-03

2. Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT);American Journal of Surgical Pathology;2024-08-02

3. Hypercalcemic Ovarian Carcinoma (Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)): A Case Series and Review of Literature of a Rare Malignancy;Indian Journal of Surgical Oncology;2024-06-25

4. Molecularly Defined Thoracic Neoplasms;Advances in Anatomic Pathology;2024-03-19

5. Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges;Pathology - Research and Practice;2023-08